2021 Calcimimetic Coverage & Reimbursement Overview - Sponsored by Amgen

When:  Jan 19, 2021 from 01:00 PM to 02:00 PM (ET)
Associated with  Open Member Community

This presentation will discuss the evolution of the end-stage renal disease (ESRD) bundle, the intent of the Transitional Drug Add-On Payment Adjustment (TDAPA), the valuation and inclusion of calcimimetics as part of the bundle for 2021, and reimbursement beyond the bundle.

Sponsored by